GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (NSE:MANKIND) » Definitions » Other Long-Term Liabilities

Mankind Pharma (NSE:MANKIND) Other Long-Term Liabilities : ₹18,325 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Other Long-Term Liabilities?

Mankind Pharma's other long-term liabilities for the quarter that ended in Mar. 2025 was ₹18,325 Mil.

Mankind Pharma's quarterly other long-term liabilities declined from Sep. 2024 (₹2,724 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹18,325 Mil).

Mankind Pharma's annual other long-term liabilities increased from Mar. 2023 (₹1,028 Mil) to Mar. 2024 (₹1,120 Mil) and increased from Mar. 2024 (₹1,120 Mil) to Mar. 2025 (₹18,325 Mil).

Mankind Pharma Other Long-Term Liabilities Historical Data

The historical data trend for Mankind Pharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Other Long-Term Liabilities Chart

Mankind Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Long-Term Liabilities
Get a 7-Day Free Trial 219.20 757.75 1,028.07 1,120.31 18,325.10

Mankind Pharma Quarterly Data
Mar20 Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,120.31 - 2,723.50 - 18,325.10

Mankind Pharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Mankind Pharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mankind Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (NSE:MANKIND) » Definitions » Other Long-Term Liabilities
Comparable Companies
BOM:500124 NSE:TORNTPHARM BOM:532321 BOM:500257 BOM:500087 NSE:AUROPHARMA BOM:500488 NSE:ALKEM BOM:543064 BOM:532296 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
543904:India
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Website
https://www.mankindpharma.com
Mankind Pharma Ltd is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors providing products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News, Gas-O-Fast, AcneStar and HealthOK. Geographically, the company derives a majority of its revenue from the sale of pharmaceutical products in India and the rest from its customers located outside India.

Mankind Pharma Headlines

No Headlines